Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor
- PMID: 2901922
- DOI: 10.1111/j.1365-2265.1988.tb03650.x
Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor
Abstract
Previous studies by us and others have shown that Graves' immunoglobulins G (IgGs) behaved as agonists or even antagonists of TSH. In this paper we have looked for the existence of IgG preparations without any thyroid stimulatory activity but able to significantly block the action of TSH in 128 hyperthyroid Graves' patients. The presence of TSH-binding inhibiting antibodies (TBIAb) and that of thyroid stimulating antibodies (TSAb) was evaluated by a radioreceptor assay using solubilized thyroid plasma membranes and by assaying the adenylate cyclase (AC) function of thyroid plasma membranes, respectively. Seventeen IgGs were negative for TSAb but positive for TBIAb in the screening, using only one concentration of IgG. Three kinds of activity were investigated in these IgGs at different doses: (1) TSH-binding inhibiting activity; (2) thyroid AC stimulating activity; and (3) the inhibition of TSH-induced AC stimulation. The results showed that the level of activity was not always dose-dependent. A significant (greater than 20%) inhibition of the TSH-dependent AC stimulation was present in 15 of the 17 IgGs examined: this inhibition was more elevated at lower than at higher doses in two preparations. No significant correlation was found between the three activities. In short, we have been able to demonstrate the existence of 'blocking' antibodies, apparently without any stimulatory activity, in some patients with Graves' disease. The diphasic pattern of the dose-response curves of some IgGs and the lack of correlation between the different activities can be explained by the co-existence in the sera of Graves' patients of different autoantibodies varying in concentration, binding affinity constant and intrinsic biological activity.
Similar articles
-
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.Clin Endocrinol (Oxf). 1989 Feb;30(2):109-19. doi: 10.1111/j.1365-2265.1989.tb03732.x. Clin Endocrinol (Oxf). 1989. PMID: 2575468
-
Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.J Clin Endocrinol Metab. 1976 Feb;42(2):341-54. doi: 10.1210/jcem-42-2-341. J Clin Endocrinol Metab. 1976. PMID: 946604
-
Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.Acta Endocrinol (Copenh). 1986 Aug;112(4):517-22. doi: 10.1530/acta.0.1120517. Acta Endocrinol (Copenh). 1986. PMID: 2875588
-
Immunology of the thyrotropin receptor.Immunol Commun. 1976;5(5):345-60. doi: 10.3109/08820137609033853. Immunol Commun. 1976. PMID: 61168 Review.
-
[The TSH receptor gene and the pathogenesis of Graves' disease].Nihon Naibunpi Gakkai Zasshi. 1992 Jun 20;68(6):584-91. doi: 10.1507/endocrine1927.68.6_584. Nihon Naibunpi Gakkai Zasshi. 1992. PMID: 1353029 Review. Japanese.
Cited by
-
Immunity to the thyroid-stimulating hormone receptor.Springer Semin Immunopathol. 1993;14(3):309-21. doi: 10.1007/BF00195980. Springer Semin Immunopathol. 1993. PMID: 8438211 Review. No abstract available.
-
Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients.J Thyroid Res. 2012;2012:182176. doi: 10.1155/2012/182176. Epub 2012 May 10. J Thyroid Res. 2012. PMID: 22655217 Free PMC article.
-
The measurement of antithyroid autoantibodies in the diagnosis and management of thyroid autoimmune disease.Clin Rev Allergy Immunol. 1998 Fall;16(3):219-25. doi: 10.1007/BF02737632. Clin Rev Allergy Immunol. 1998. PMID: 9773249 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources